help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Journal of Clinical Endocrinology & Metabolism Vol. 53, No. 1 192-199
doi:10.1210/jcem-53-1-192
Copyright © 1981 by the Endocrine Society.
This Article
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by FORNEY, J. P.
Right arrow Articles by MACDONALD, P. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by FORNEY, J. P.
Right arrow Articles by MACDONALD, P. C.

Aromatization of Androstenedione to Estrone by Human Adipose Tissue in Vitro. Correlation with Adipose Tissue Mass, Age, and Endometrial Neoplasia*

J. PETER FORNEY, LEON MILEWICH, GRACE T. CHEN, JUDY L. GARLOCK, BARRY E. SCHWARZ, CLARE D. EDMAN and PAUL C. MACDONALD

Cecil H. and Ida Green Center for Reproductive Biology Sciences, and the Department of Obstetrics and Gynecology and Biochemistry, The University of Texas Southwestern Medical School at Dallas, Dallas, Texas 75235

Address correspondence and requests for reprints to: J. Peter Forney, M.D., Department of Obstetrics and Gynecology, The University of Texas Southwestern Medical School, 5323 Harry Hines Boulevard, Dallas, Texas 75235.

To explore the relationship between extraglandular estrogen formation and the clinical parameters of age, weight, and endometrial neoplasia, an assay was developed to measure the rate of estrogen formation from androgen precursors in human adipose tissue. The substrate, [3H]androstenedione, was more efficient than [3H]testosterone for the aromatase system in this tissue. The highest rate of conversion of androgen to estrogen occurred in tissue slices rather than in minces or microsomal preparations. The addition of cofactor NADPH was not required for aromatization in slices or minces, probably as a consequence of endogenous production of NADPH by the tissue. [3H]Estrone was the sole estrogenic product identified in incubations when [3H]androstenedione was used as the substrate, whereas [3H]estradiol-17/β was the exclusive estrogen detected when using [3H]testosterone. The rate of [3H]estrone formation from [3H]androstenedione in tissue slices was linear with time of incubation up to 2 h and with tissue mass up to 1.0 g. The optimal temperature for aromatase activity in these tissues was 37 C, and the apparent Km of adipose tissue aromatase for androstenedione was 0.25 /µM. A method was also developed to measure DNA content in the tissue slices used for incubation. When the conversion rates of [3H]androstenedione to [3H]estrone and DNA content were measured in adipose tissue obtained from the abdominal wall of 48 women, 17 women with and 31 women without endometrial neoplasia, the rate of conversion of androstenedione to estrone per unit mass of adipose tissue (g) correlated significantly with calculated body component mass of adipose tissue as well as with calculated unit cell number (106 cells) present in adipose tissue. There was no correlation with age. Moreover, the mean rate of estrone production in the adipose tissue obtained from women with endometrial hyperplasia or carcinoma was significantly higher than that obtained from equivalent weight women without endometrial neoplasia.

* This work was supported in part by USPHS Grant PO1-HD11149

Received December 12, 1980.




This article has been cited by other articles:


Home page
Br. J. Sports. Med.Home page
C M Friedenreich and A E Cust
Physical activity and breast cancer risk: impact of timing, type and dose of activity and population subgroup effects
Br. J. Sports Med., August 1, 2008; 42(8): 636 - 647.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
N. Napoli, S. Donepudi, S. Sheikh, G. B. Rini, and R. Armamento-Villareal
Increased 2-Hydroxylation of Estrogen in Women with a Family History of Osteoporosis
J. Clin. Endocrinol. Metab., April 1, 2005; 90(4): 2035 - 2041.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
G. A. Brown, M. D. Vukovich, E. R. Martini, M. L. Kohut, W. D. Franke, D. A. Jackson, and D. S. King
Endocrine Responses to Chronic Androstenedione Intake in 30- to 56-Year-Old Men
J. Clin. Endocrinol. Metab., November 1, 2000; 85(11): 4074 - 4080.
[Abstract] [Full Text]


Home page
JAMAHome page
B. Z. Leder, C. Longcope, D. H. Catlin, B. Ahrens, D. A. Schoenfeld, and J. S. Finkelstein
Oral Androstenedione Administration and Serum Testosterone Concentrations in Young Men
JAMA, February 9, 2000; 283(6): 779 - 782.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
S. K. Lim, Y. J. Won, J. H. Lee, S. H. Kwon, E. J. Lee, K. R. Kim, H. C. Lee, K. B. Huh, and B. C. Chung
Altered Hydroxylation of Estrogen in Patients with Postmenopausal Osteopenia
J. Clin. Endocrinol. Metab., April 1, 1997; 82(4): 1001 - 1006.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1981 by The Endocrine Society